Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

Stage 3 lower case b

Known as: stage 3b, stage iiib 
 
National Institutes of Health

Related topics

Related topics

1 relation
Stage 3B

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2018
Review
2018
The Integration of Radiotherapy with Immunotherapy for the Treatment of Non–Small Cell Lung Cancer
Five-year survival rates for non–small cell lung cancer (NSCLC) range from 14% to 49% for stage I to stage IIIA disease, and are… Expand
  • figure 1
  • figure 2
  • figure 3
Highly Cited
2011
Highly Cited
2011
The role of NF-E2-related factor 2 in predicting chemoresistance and prognosis in advanced non-small-cell lung cancer.
BACKGROUND NF-E2-related factor 2 (Nrf2) plays an important role in platinum chemoresistance by activating transcription of… Expand
  • figure 1
  • table 1
  • table 2
  • figure 2
  • figure 3
Highly Cited
2009
Highly Cited
2009
Vascularized iliac bone-grafting for osteonecrosis with segmental collapse of the femoral head.
BACKGROUND Vascularized iliac bone-grafting has been reported to be successful for patients with osteonecrosis of the femoral… Expand
  • figure 1
  • figure 2
  • figure 3
2007
2007
Prognostic Factors Affecting Locoregional Recurrence in Patients with Stage IIIB Noninflammatory Breast Cancer
BackgroundThe aim of the present study was to identify the clinicopathological factors affecting locoregional recurrence (LRR) in… Expand
  • table 1
  • figure 1
  • table 2
  • table 3
  • figure 2
Highly Cited
2004
Highly Cited
2004
Prognostic indicators and survival in patients with stage IIIB inflammatory breast carcinoma after dose-intense chemotherapy.
PURPOSE To improve treatment outcome for patients presenting with inflammatory breast cancer (IBC), we have sequentially… Expand
Highly Cited
2004
Highly Cited
2004
Quality of life assessment of second-line docetaxel versus best supportive care in patients with non-small-cell lung cancer previously treated with platinum-based chemotherapy: results of a…
PURPOSE AND METHODS Docetaxel second-line chemotherapy for non-small-cell lung cancer (NSCLC) has previously been shown to… Expand
Highly Cited
2002
Highly Cited
2002
Predictors of local-regional recurrence after neoadjuvant chemotherapy and mastectomy without radiation.
PURPOSE To define clinical and pathologic predictors of local-regional recurrence (LRR) for patients treated with neoadjuvant… Expand
Highly Cited
1999
Highly Cited
1999
Cisplatin, gemcitabine, and vinorelbine combination therapy in advanced non-small-cell lung cancer: a phase II randomized study of the Southern Italy Cooperative Oncology Group.
PURPOSE In a previous phase I study cisplatin (CDDP), gemcitabine (GEM), and vinorelbine (VNR) combination therapy was safe and… Expand
1998
1998
Possible role of glutathione in predicting radiotherapy response of cervix cancer.
PURPOSE To see if changes in tumor/blood glutathione (GSH) levels after one fraction of radiotherapy can be correlated with the… Expand
Highly Cited
1997
Highly Cited
1997
Prognostic value of pleural effusion in patients with non-small cell lung cancer.
This study was performed to determine whether pleural effusion in patients with advanced non-small cell lung cancer (NSCLC) has a… Expand
  • table 1
  • table 2
  • figure 2
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy, Terms of Service, and Dataset License
ACCEPT & CONTINUE